ES2105524T3 - Procedimiento para la formacion de monohidrato de loracarbef cristalino. - Google Patents

Procedimiento para la formacion de monohidrato de loracarbef cristalino.

Info

Publication number
ES2105524T3
ES2105524T3 ES94303946T ES94303946T ES2105524T3 ES 2105524 T3 ES2105524 T3 ES 2105524T3 ES 94303946 T ES94303946 T ES 94303946T ES 94303946 T ES94303946 T ES 94303946T ES 2105524 T3 ES2105524 T3 ES 2105524T3
Authority
ES
Spain
Prior art keywords
procedure
formation
loracarbef monohydrate
crystalline
crystalline loracarbef
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94303946T
Other languages
English (en)
Inventor
Robert Louis Nist
Marvin Emanuel Wildfeuer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2105524T3 publication Critical patent/ES2105524T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCESO PARA LA PREPARACION DE LA ESTRUCTURA DE MONOHIDRATO CRISTALINO DEL COMPUESTO DE LA FORMULA (I) QUE CONSISTE EN MEZCLAR UNA ESTRUCTURA DE LORACARBEF, DISTINTA DEL MONOHIDRATO CRISTALINO, TAL COMO LA ESTRUCTURA DE CRISTAL DE ETANOL, CRISTAL DE ACETONA, DIHIDRATO CRISTALINO, CRISTAL DE ACETONITRILO, CRISTAL DE METANOL, CRISTAL DE PROPANOL, CRISTAL DE ACETATO DE ETILO, CRISTAL DE CLORURO DE METILENO, BIS(DMF) CRISTALINO Y MONO(DMF) CRISTALINO, EN AGUA A UNA TEMPERATURA ENTRE 30 (GRADOS) C APROXIMADAMENTE Y 60 (GRADOS) C APROXIMADAMENTE, Y PREFERENTEMENTE A UNA TEMPERATURA ENTRE 40 (GRADOS) C Y 50 (GRADOS) C. LA CONVERSION TAMBIEN SE PUEDE LLEVAR A CABO EXPONIENDO LA ESTRUCTURA DE LORACARBEF A UN VAPOR SATURADO A UNA TEMPERATURA ENTRE 90 (GRADOS) C APROXIMADAMENTE Y 100 (GRADOS) C APROXIMADAMENTE. OTRO ASPECTO DE LA INVENCION ES LA PREPARACION DE LAS ESTRUCTURAS DE CRISTAL ARRIBA MENCIONADAS A BASE DE FORMAR UNA LECHADA DE LA ESTRUCTURA DEL SOLVATO DE BIS(DMF) DEL COMPUESTO DE LA FORMULA (I) CON EL SOLVENTE RESPECTIVO.
ES94303946T 1993-06-04 1994-06-01 Procedimiento para la formacion de monohidrato de loracarbef cristalino. Expired - Lifetime ES2105524T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/071,552 US5352782A (en) 1993-06-04 1993-06-04 Process for preparing crystalline β-lactam monohydrate

Publications (1)

Publication Number Publication Date
ES2105524T3 true ES2105524T3 (es) 1997-10-16

Family

ID=22102062

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94303946T Expired - Lifetime ES2105524T3 (es) 1993-06-04 1994-06-01 Procedimiento para la formacion de monohidrato de loracarbef cristalino.

Country Status (29)

Country Link
US (1) US5352782A (es)
EP (1) EP0627431B1 (es)
JP (1) JPH06345761A (es)
KR (1) KR950000702A (es)
CN (1) CN1045296C (es)
AT (1) ATE156129T1 (es)
AU (1) AU682503B2 (es)
BR (1) BR9402150A (es)
CA (1) CA2125000A1 (es)
CO (1) CO4230099A1 (es)
CZ (1) CZ284225B6 (es)
DE (1) DE69404560T2 (es)
DK (1) DK0627431T3 (es)
ES (1) ES2105524T3 (es)
FI (1) FI942632A (es)
GR (1) GR3024989T3 (es)
HU (1) HU217067B (es)
IL (1) IL109870A (es)
MY (1) MY110725A (es)
NO (1) NO307052B1 (es)
NZ (1) NZ260652A (es)
PE (1) PE13295A1 (es)
PH (1) PH30184A (es)
PL (1) PL174535B1 (es)
RU (1) RU2130456C1 (es)
TW (1) TW449596B (es)
UA (1) UA34440C2 (es)
YU (1) YU33494A (es)
ZA (1) ZA943826B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5580977A (en) * 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
US20060205938A1 (en) * 2002-11-21 2006-09-14 Yatendra Kumar Monohydrate solvates of loracarbef

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3502663A (en) * 1969-04-21 1970-03-24 Lilly Co Eli Crystalline cephalosporin,method for its manufacture
US3531481A (en) * 1969-04-21 1970-09-29 Lilly Co Eli Method for manufacture of crystalline cephalosporin
DD273634A5 (de) * 1987-10-06 1989-11-22 ����@�����@�����@����k�� Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic
CA2034592C (en) * 1990-01-26 2001-06-05 Ralph R. Pfeiffer Crystalline hydrochloride of new beta-lactam antibiotic and process therefor

Also Published As

Publication number Publication date
TW449596B (en) 2001-08-11
HU217067B (hu) 1999-11-29
CN1097755A (zh) 1995-01-25
NO942049L (no) 1994-12-05
BR9402150A (pt) 1994-12-27
RU2130456C1 (ru) 1999-05-20
CA2125000A1 (en) 1994-12-05
DE69404560D1 (de) 1997-09-04
EP0627431A1 (en) 1994-12-07
FI942632A (fi) 1994-12-05
YU33494A (sh) 1996-10-18
HUT67975A (en) 1995-05-29
JPH06345761A (ja) 1994-12-20
AU682503B2 (en) 1997-10-09
NZ260652A (en) 1995-09-26
CO4230099A1 (es) 1995-10-19
DE69404560T2 (de) 1997-12-18
NO307052B1 (no) 2000-01-31
CZ284225B6 (cs) 1998-09-16
PL174535B1 (pl) 1998-08-31
HU9401674D0 (en) 1994-09-28
DK0627431T3 (da) 1997-08-25
KR950000702A (ko) 1995-01-03
IL109870A (en) 1998-06-15
IL109870A0 (en) 1994-10-07
PH30184A (en) 1997-01-21
ATE156129T1 (de) 1997-08-15
UA34440C2 (uk) 2001-03-15
RU94019423A (ru) 1996-04-20
EP0627431B1 (en) 1997-07-30
FI942632A0 (fi) 1994-06-03
US5352782A (en) 1994-10-04
GR3024989T3 (en) 1998-01-30
MY110725A (en) 1999-01-30
CZ134194A3 (en) 1994-12-15
NO942049D0 (no) 1994-06-02
PL303677A1 (en) 1995-01-09
AU6451794A (en) 1994-12-08
PE13295A1 (es) 1995-05-24
ZA943826B (en) 1995-12-01
CN1045296C (zh) 1999-09-29

Similar Documents

Publication Publication Date Title
ES545899A0 (es) Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disodico
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DZ2912A1 (fr) Procédé pour la préparation de pyrazolo Ä4,3-DÜpyrimidine-7-ones, et intermédiaires pour ce procédé.
FI884720A (fi) Kompositioner foer anvaendning som kontrastmedel.
ES2105524T3 (es) Procedimiento para la formacion de monohidrato de loracarbef cristalino.
ES521764A0 (es) Un procedimiento para la preparacion de una amida de un dipeptido l-aspartil-d-aminoacido.
ES538579A0 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
NO981818D0 (no) FremgangsmÕte for Õ mobilisere hematopoetiske stamceller
DK159450C (da) 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin b og farmaceutisk acceptable syreadditionssalte deraf samt 9-deoxo-9a-aza-9a-homoerythromycin b til anvendelse som mellemprodukt ved fremstilling deraf
MX160579A (es) Procedimiento para producir derivados de hidantoina
DK68784D0 (da) Kontinuert fremgangsmade til fremstilling af 5-oxo-2,4-dichlor-4-substituerede pentannitriler
FR2711648B1 (fr) Procédé de purification du 1,1,1,2-tétrafluoroéthane.
FR2633449B1 (fr) Procede de remise en forme de pieces localement deteriorees, notamment anticathodes
FI963243A (fi) Menetelmä 2-butyyli-2-etyyli-1,3-propaanidiolin valmistamiseksi
ES2066413T3 (es) Procedimiento para la purificacion de n,n-dietilmandelamida.
ES536054A0 (es) Un procedimiento para la preparacion de nuevos 4 (3h)-pirimidonas 2,5-disustituidas.
ES557654A0 (es) Procedimiento de obtencion de nuevos compuestos estilbenicos para aclaradores opticos.
ES516152A0 (es) Procedimiento para la produccion de nuevos derivados de 4-fenil-3,5-dicarboxi-1,4-dihidro-piridina.
DK0813518T3 (da) Fremgangsmåde til fremstilling af alfa,beta-diaminoacrylnitriler
ES520097A0 (es) Procedimiento para la obtencion de nuevas imidazo (i,2-a)pirimidinas.
CO4480762A1 (es) Un procedimiento de obtencion de dihidrato de azitromicina
NO179882C (no) Fremgangsmåte til fremstilling av lange, isolerte rör i form av en sandwich-konstruksjon
ES1031821Y (es) Nueva estructura de tres apoyos para superficies horizontales.
ES264119Y (es) "soporte perfeccionado para la fijacion mural de baldas".
FR2711135B1 (fr) Procédé de purification du 1,1,1,2-tétrafluoroéthane.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 627431

Country of ref document: ES